Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils. [electronic resource]
Producer: 20061215Description: 6915-23 p. digitalISSN:- 0950-9232
- 3-Phosphoinositide-Dependent Protein Kinases
- Animals
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Apoptosis -- drug effects
- Bone Marrow -- drug effects
- Cells, Cultured
- Doxorubicin -- adverse effects
- Female
- Flow Cytometry
- Humans
- Immunoblotting
- Inhibitor of Apoptosis Proteins
- Lymphoma -- drug therapy
- Mice
- Mice, Inbred C57BL
- Microtubule-Associated Proteins -- drug effects
- Neoplasm Proteins -- drug effects
- Neoplasms, Experimental -- drug therapy
- Neutrophils -- cytology
- Phosphatidylinositol 3-Kinases -- drug effects
- Polymerase Chain Reaction
- Protein Serine-Threonine Kinases -- drug effects
- Proto-Oncogene Proteins c-akt -- drug effects
- Sirolimus -- adverse effects
- Stem Cells -- drug effects
- Survivin
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.